uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Eladynos
Refused
Human
Details
EMA number
EMEA/H/C/004157
ATC code
H05AA
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of osteoporosis.
MeSH:
Osteoporosis
Group:
Calcium homeostasis
Active substances
abaloparatide
Marketing Authorisation Holder
Theramex Ireland Limited
MAH
Radius Health Ireland Ltd
MAH
Timeline
Filter by authority:
EMA
Eladynos authorised
12 Dec 2022
authorised
regulatory
Status changed: Authorised → Refused
14 Feb 2019
status_changed
regulatory
Eladynos | uMedical